Literature DB >> 11893227

Management of fibromyalgia: what are the best treatment choices?

Karin Ø Forseth K1, Jan T Gran.   

Abstract

Fibromyalgia still represents an enigma to modern medicine and the aetiopathogenesis is far from explored. The management of patients with fibromyalgia is thus mostly based on empirical research, and only a few controlled studies have been performed. Basic drug therapy rests on the administration of amitriptyline and conventional analgesics. Such therapy should be initiated only after careful patient information and delineation of therapeutic goals are provided. Any drug therapy should be administered in combination with physical treatment and cognitive behavioural therapy. Because of the appearing contours of pathogenic mechanisms, hopefully a number of new drugs will be available to the patients with this complex pain syndrome in the near future.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893227     DOI: 10.2165/00003495-200262040-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  122 in total

1.  Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.

Authors:  C Z Hong; T C Hsueh
Journal:  Arch Phys Med Rehabil       Date:  1996-11       Impact factor: 3.966

2.  Familial occurrence of primary fibromyalgia.

Authors:  M J Pellegrino; G W Waylonis; A Sommer
Journal:  Arch Phys Med Rehabil       Date:  1989-01       Impact factor: 3.966

3.  Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.

Authors:  Henning Vaerøy; Robert Helle; Øystein Førre; Erik Kåss; Lars Terenius
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

4.  An in-depth study of long-term users of transcutaneous electrical nerve stimulation (TENS). Implications for clinical use of TENS.

Authors:  M I Johnson; C H Ashton; J W Thompson
Journal:  Pain       Date:  1991-03       Impact factor: 6.961

5.  Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

Authors:  S Carette; G A McCain; D A Bell; A G Fam
Journal:  Arthritis Rheum       Date:  1986-05

6.  Electroacupuncture in fibromyalgia: results of a controlled trial.

Authors:  C Deluze; L Bosia; A Zirbs; A Chantraine; T L Vischer
Journal:  BMJ       Date:  1992-11-21

7.  Assessment of nonarticular tenderness and prevalence of fibromyalgia in children.

Authors:  D Buskila; J Press; A Gedalia; M Klein; L Neumann; R Boehm; S Sukenik
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

8.  Primary fibromyalgia. A clinical and laboratory study of 55 patients.

Authors:  A Bengtsson; K G Henriksson; L Jorfeldt; B Kågedal; C Lennmarken; F Lindström
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

9.  Fibrositis syndrome: a historical perspective.

Authors:  H Smythe
Journal:  J Rheumatol Suppl       Date:  1989-11

10.  Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia.

Authors:  Per Kristian Eide; Audun Stubhaug; Ivar Øye; Harald Breivik
Journal:  Pain       Date:  1995-05       Impact factor: 6.961

View more
  12 in total

Review 1.  Physical therapy and other nonpharmacologic approaches to fibromyalgia management.

Authors:  Ron Blehm
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 2.  Advances in the assessment of fibromyalgia.

Authors:  David A Williams; Stephen Schilling
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

Review 3.  Pregabalin: a review of its use in fibromyalgia.

Authors:  Katherine A Lyseng-Williamson; M Asif A Siddiqui
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Effects of Stanger bath therapy on fibromyalgia.

Authors:  Emel Eksioglu; Duygu Yazar; Ajda Bal; Hicran Demir Usan; Aytul Cakci
Journal:  Clin Rheumatol       Date:  2006-07-29       Impact factor: 2.980

5.  Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.

Authors:  Nicole M Marlow; Kit N Simpson; Ivana A Vaughn; Ara Jo; James S Zoller; Edward B Short
Journal:  Pain Pract       Date:  2017-05-28       Impact factor: 3.183

Review 6.  Patient-Reported Outcomes and Fibromyalgia.

Authors:  David A Williams; Anna L Kratz
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

Review 7.  Evaluation of treatments for myofascial pain syndrome and fibromyalgia.

Authors:  Nathan J Rudin
Journal:  Curr Pain Headache Rep       Date:  2003-12

Review 8.  Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia.

Authors:  David A Williams; Richard H Gracely
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Comparing common reasons for inpatient and outpatient visits between commercially-insured duloxetine or pregabalin initiators with fibromyalgia.

Authors:  Yang Zhao; Peter Sun; Mark Bernauer
Journal:  J Pain Res       Date:  2012-10-31       Impact factor: 3.133

10.  Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.

Authors:  X Peng; P Sun; D Novick; J Andrews; S Sun
Journal:  J Pain Res       Date:  2014-01-09       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.